Resultados de la búsqueda 261-270 of 1190 for ❤정품 레비트라 구매대행 {정력원.COM} 칵스타 온라인 구매❤

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving ...

  2. Oncología (médica) - Ensayos clínicos

    Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding ...

  3. Oncología (médica) - Ensayos clínicos

    Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps ...

  4. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...

  6. Oncología (médica) - Ensayos clínicos

    Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...

  7. Medicina cardiovascular - Ensayos clínicos

    Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this trial is to compare the usual treatment alone to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to create a long-term, prospective database of cutaneous lymphoma that will lead to a better understanding of the biological ...

  10. Oncología (médica) - Ensayos clínicos

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...